Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in parkinson's disease

Ian Martin, Jungwoo Wren Kim, Byoung Dae Lee, Ho Chul Kang, Jinchong Xu, Hao Jia, Jeannette Stankowski, Min Sik Kim, Jun Zhong, Manoj Kumar, Shaida A. Andrabi, Yulan Xiong, Dennis W. Dickson, Zbigniew K. Wszolek, Akhilesh Pandey, Ted M Dawson, Valina Dawson

Research output: Contribution to journalArticle

Abstract

Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and sporadic Parkinson's disease (PD). Elevated LRRK2 kinase activity and neurodegeneration are linked, but the phosphosubstrate that connects LRRK2 kinase activity to neurodegeneration is not known. Here, we show that ribosomal protein s15 is a key pathogenic LRRK2 substrate in Drosophila and human neuron PD models. Phosphodeficient s15 carrying a threonine 136 to alanine substitution rescues dopamine neuron degeneration and age-related locomotor deficits in G2019S LRRK2 transgenic Drosophila and substantially reduces G2019S LRRK2-mediated neurite loss and cell death in human dopamine and cortical neurons. Remarkably, pathogenic LRRK2 stimulates both cap-dependent and cap-independent mRNA translation and induces a bulk increase in protein synthesis in Drosophila, which can be prevented by phosphodeficient T136A s15. These results reveal a novel mechanism of PD pathogenesis linked to elevated LRRK2 kinase activity and aberrant protein synthesis in vivo.

Original languageEnglish (US)
Pages (from-to)472-485
Number of pages14
JournalCell
Volume157
Issue number2
DOIs
StatePublished - Apr 10 2014

Fingerprint

Phosphorylation
Leucine
Parkinson Disease
Phosphotransferases
Neurons
Dopaminergic Neurons
Dopamine
ribosomal protein S15
Nerve Degeneration
Protein Biosynthesis
Neurites
Cell death
Threonine
Alanine
Drosophila
Proteins
Cell Death
Substitution reactions
Messenger RNA
Mutation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in parkinson's disease. / Martin, Ian; Kim, Jungwoo Wren; Lee, Byoung Dae; Kang, Ho Chul; Xu, Jinchong; Jia, Hao; Stankowski, Jeannette; Kim, Min Sik; Zhong, Jun; Kumar, Manoj; Andrabi, Shaida A.; Xiong, Yulan; Dickson, Dennis W.; Wszolek, Zbigniew K.; Pandey, Akhilesh; Dawson, Ted M; Dawson, Valina.

In: Cell, Vol. 157, No. 2, 10.04.2014, p. 472-485.

Research output: Contribution to journalArticle

Martin, I, Kim, JW, Lee, BD, Kang, HC, Xu, J, Jia, H, Stankowski, J, Kim, MS, Zhong, J, Kumar, M, Andrabi, SA, Xiong, Y, Dickson, DW, Wszolek, ZK, Pandey, A, Dawson, TM & Dawson, V 2014, 'Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in parkinson's disease', Cell, vol. 157, no. 2, pp. 472-485. https://doi.org/10.1016/j.cell.2014.01.064
Martin, Ian ; Kim, Jungwoo Wren ; Lee, Byoung Dae ; Kang, Ho Chul ; Xu, Jinchong ; Jia, Hao ; Stankowski, Jeannette ; Kim, Min Sik ; Zhong, Jun ; Kumar, Manoj ; Andrabi, Shaida A. ; Xiong, Yulan ; Dickson, Dennis W. ; Wszolek, Zbigniew K. ; Pandey, Akhilesh ; Dawson, Ted M ; Dawson, Valina. / Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in parkinson's disease. In: Cell. 2014 ; Vol. 157, No. 2. pp. 472-485.
@article{45bc259142df475aa2faf51cb713b31c,
title = "Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in parkinson's disease",
abstract = "Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and sporadic Parkinson's disease (PD). Elevated LRRK2 kinase activity and neurodegeneration are linked, but the phosphosubstrate that connects LRRK2 kinase activity to neurodegeneration is not known. Here, we show that ribosomal protein s15 is a key pathogenic LRRK2 substrate in Drosophila and human neuron PD models. Phosphodeficient s15 carrying a threonine 136 to alanine substitution rescues dopamine neuron degeneration and age-related locomotor deficits in G2019S LRRK2 transgenic Drosophila and substantially reduces G2019S LRRK2-mediated neurite loss and cell death in human dopamine and cortical neurons. Remarkably, pathogenic LRRK2 stimulates both cap-dependent and cap-independent mRNA translation and induces a bulk increase in protein synthesis in Drosophila, which can be prevented by phosphodeficient T136A s15. These results reveal a novel mechanism of PD pathogenesis linked to elevated LRRK2 kinase activity and aberrant protein synthesis in vivo.",
author = "Ian Martin and Kim, {Jungwoo Wren} and Lee, {Byoung Dae} and Kang, {Ho Chul} and Jinchong Xu and Hao Jia and Jeannette Stankowski and Kim, {Min Sik} and Jun Zhong and Manoj Kumar and Andrabi, {Shaida A.} and Yulan Xiong and Dickson, {Dennis W.} and Wszolek, {Zbigniew K.} and Akhilesh Pandey and Dawson, {Ted M} and Valina Dawson",
year = "2014",
month = "4",
day = "10",
doi = "10.1016/j.cell.2014.01.064",
language = "English (US)",
volume = "157",
pages = "472--485",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in parkinson's disease

AU - Martin, Ian

AU - Kim, Jungwoo Wren

AU - Lee, Byoung Dae

AU - Kang, Ho Chul

AU - Xu, Jinchong

AU - Jia, Hao

AU - Stankowski, Jeannette

AU - Kim, Min Sik

AU - Zhong, Jun

AU - Kumar, Manoj

AU - Andrabi, Shaida A.

AU - Xiong, Yulan

AU - Dickson, Dennis W.

AU - Wszolek, Zbigniew K.

AU - Pandey, Akhilesh

AU - Dawson, Ted M

AU - Dawson, Valina

PY - 2014/4/10

Y1 - 2014/4/10

N2 - Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and sporadic Parkinson's disease (PD). Elevated LRRK2 kinase activity and neurodegeneration are linked, but the phosphosubstrate that connects LRRK2 kinase activity to neurodegeneration is not known. Here, we show that ribosomal protein s15 is a key pathogenic LRRK2 substrate in Drosophila and human neuron PD models. Phosphodeficient s15 carrying a threonine 136 to alanine substitution rescues dopamine neuron degeneration and age-related locomotor deficits in G2019S LRRK2 transgenic Drosophila and substantially reduces G2019S LRRK2-mediated neurite loss and cell death in human dopamine and cortical neurons. Remarkably, pathogenic LRRK2 stimulates both cap-dependent and cap-independent mRNA translation and induces a bulk increase in protein synthesis in Drosophila, which can be prevented by phosphodeficient T136A s15. These results reveal a novel mechanism of PD pathogenesis linked to elevated LRRK2 kinase activity and aberrant protein synthesis in vivo.

AB - Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and sporadic Parkinson's disease (PD). Elevated LRRK2 kinase activity and neurodegeneration are linked, but the phosphosubstrate that connects LRRK2 kinase activity to neurodegeneration is not known. Here, we show that ribosomal protein s15 is a key pathogenic LRRK2 substrate in Drosophila and human neuron PD models. Phosphodeficient s15 carrying a threonine 136 to alanine substitution rescues dopamine neuron degeneration and age-related locomotor deficits in G2019S LRRK2 transgenic Drosophila and substantially reduces G2019S LRRK2-mediated neurite loss and cell death in human dopamine and cortical neurons. Remarkably, pathogenic LRRK2 stimulates both cap-dependent and cap-independent mRNA translation and induces a bulk increase in protein synthesis in Drosophila, which can be prevented by phosphodeficient T136A s15. These results reveal a novel mechanism of PD pathogenesis linked to elevated LRRK2 kinase activity and aberrant protein synthesis in vivo.

UR - http://www.scopus.com/inward/record.url?scp=84898622052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898622052&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2014.01.064

DO - 10.1016/j.cell.2014.01.064

M3 - Article

C2 - 24725412

AN - SCOPUS:84898622052

VL - 157

SP - 472

EP - 485

JO - Cell

JF - Cell

SN - 0092-8674

IS - 2

ER -